Insulet (PODD) Net Equity Issued and Repurchased (2010 - 2019)
Insulet's (PODD) quarterly Net Equity Issued and Repurchased came in at -$9.1 million in Q2 2019, down 209.9% YoY from $8.2 million in Q2 2018, and down 200.0% on a QoQ basis from $9.1 million in Q1 2019.
Insulet (PODD) Net Equity Issued and Repurchased (2010 - 2019) Analysis & Trends
Insulet (PODD) has 10 years of Net Equity Issued and Repurchased data on file, last reported at -$9.1 million in Q2 2019.
- Quarterly Net Equity Issued and Repurchased fell 209.9% year-over-year to -$9.1 million in Q2 2019, while the trailing twelve-month figure through Sep 2020 was -$9.1 million (up 32.7% YoY) and the FY2020 annual result came in at $477.5 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased declined to -$9.1 million in Q2 2019, from $9.1 million in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $9.1 million in Q1 2019 to a low of -$13.5 million in Q4 2018.
- A 5-year average of $1.4 million and a median of $1.6 million in 2015 frame the typical range for Net Equity Issued and Repurchased.
- Annual changes were most pronounced in 2017 — Net Equity Issued and Repurchased jumped 695.85% — and 2019, when it plunged 209.9%.
- Tracing PODD's Net Equity Issued and Repurchased over 5 years: stood at $808000.0 in 2015, then tumbled by 99.26% to $6000.0 in 2016, then jumped by 47300.0% to $2.8 million in 2017, then sank by 573.42% to -$13.5 million in 2018, then surged by 32.7% to -$9.1 million in 2019.
- The last three Net Equity Issued and Repurchased figures came in at -$9.1 million (Q2 2019), $9.1 million (Q1 2019), and -$13.5 million (Q4 2018), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | - |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | - |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | - |
| 10 | Insulet | 10.35 Bn | 9.82 Bn | 562.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | -9.06 Mn |
| Jun 30, 2019 | -9.06 Mn |
| Mar 31, 2019 | 9.06 Mn |
| Mar 31, 2019 | 9.06 Mn |
| Dec 31, 2018 | -13.46 Mn |
| Dec 31, 2018 | -13.46 Mn |
| Sep 30, 2018 | 2.26 Mn |
| Sep 30, 2018 | 2.26 Mn |
| Jun 30, 2018 | 8.25 Mn |
| Jun 30, 2018 | 8.25 Mn |
| Mar 31, 2018 | 2.96 Mn |
| Mar 31, 2018 | 2.96 Mn |
| Sep 30, 2017 | 2.84 Mn |
| Sep 30, 2017 | 2.84 Mn |
| Jun 30, 2017 | 1.56 Mn |
| Jun 30, 2017 | 1.56 Mn |
| Mar 31, 2017 | 6.34 Mn |
| Mar 31, 2017 | 6.34 Mn |
| Dec 31, 2016 | 6,000.00 |
| Dec 31, 2016 | 6,000.00 |